Show simple item record

dc.contributor.convenorGillian Buckleyen_AU
dc.contributor.authorBox, Robyn C.en_US
dc.contributor.authorBarram, Jen_US
dc.contributor.authorChiwenga, Len_US
dc.contributor.authorLloyd, Den_US
dc.contributor.authorLaakso, Liisaen_US
dc.date.accessioned2017-05-03T14:11:57Z
dc.date.available2017-05-03T14:11:57Z
dc.date.issued2010en_US
dc.date.modified2011-09-08T06:58:28Z
dc.identifier.urihttp://hdl.handle.net/10072/38284
dc.description.abstractObjective: To determine parameters of low-level laser therapy (LLLT) which provide clinically significant changes in breast cancer related lymphoedema (BCRL). Method: An audit of 22 women with BCRL treated with LLLT as an adjunct to conservative treatment within a private physiotherapy clinic setting. Characteristics of BCRL were a clinical presentation of soft pitting oedema in the medial aspect of the forearm, with palpable fibrotic/thickening changes. Mean age was 60.1 years (+13.78) with onset of BCRL at 1.93 years (+ 3.95) and a mean duration of 3.29 years (+ 3.14). The Riancorp LTU-904 provided an average LLLT dose of 4.42J (+ 0.81J) with manual lymphatic drainage treatment which may have included compression therapy between sessions. Results: During LLLT treatment, clinical changes in lymphoedema presentation were reflected by significant changes in the Miller Palpation rating of oedema (p<0.5). Other measures did not reach statistical significance but women reported reduction in the presence of ache, heaviness and tightness. Limb circumference and bioimpedance measurements did not change following treatment for the cohort overall but individual women had sustained changes over time. Correlations between dosage and clinical parameters were investigated to identify a clinical protocol for use in a randomized controlled study. Conclusions: LLLT may be a useful adjunct to conventional physiotherapy techniques for lymphoedema treatment in symptom reduction and softening of oedema. From the data collected, it is not clear if there is a specific set of parameters and dosage of LLLT which may provide objective improvement in BCRL.en_US
dc.description.publicationstatusYesen_AU
dc.format.extent964079 bytes
dc.format.mimetypeapplication/pdf
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisher8th Australasian Lymphology Associationen_US
dc.publisher.placeMelbourneen_US
dc.publisher.urihttp://lymphology.asn.au/new/documents/SE-03_Box.pdfen_AU
dc.relation.ispartofstudentpublicationNen_AU
dc.relation.ispartofconferencename8th Australasian Lymphology Association Conference: Reflections of the past, Inspirations for the fuen_US
dc.relation.ispartofconferencetitle8th Australasian Lymphology Association Conference: Reflections of the past, Inspirations for the futureen_US
dc.relation.ispartofdatefrom2010-05-27en_US
dc.relation.ispartofdateto2010-05-29en_US
dc.relation.ispartoflocationMelbourneen_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchComplementary and Alternative Medicine not elsewhere classifieden_US
dc.subject.fieldofresearchcode110499en_US
dc.titleLow-level laser therapy: an adjunct therapy for the treatment of breast cancer related arm lymphoedemaen_US
dc.typeConference outputen_US
dc.type.descriptionE3 - Conference Publications (Extract Paper)en_US
dc.type.codeE - Conference Publicationsen_US
gro.rights.copyrightCopyright remains with the authors 2010. The attached file is reproduced here in accordance with the copyright policy of the publisher. For information about this conference please refer to the conference's website or contact the authors.en_AU
gro.date.issued2010
gro.hasfulltextFull Text


Files in this item

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record